Status:
COMPLETED
Multidisciplinary Rehabilitation Program for Treatment-Resistant Psychotic Forensic Patients: A Comparative Study
Lead Sponsor:
Oman Ministry of Health
Conditions:
Schizophenia Disorder
Forensic Psychiatric Patients
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
This study employs a quasi-experimental design to evaluate the effectiveness of a 6-month multidisciplinary rehabilitation program integrating psychodynamic group therapy, art therapy, music therapy, ...
Detailed Description
Forensic psychiatric patients with treatment-resistant psychotic symptoms often experience persistent cognitive, functional, and social deficits, posing significant challenges to rehabilitation. Tradi...
Eligibility Criteria
Inclusion
- Diagnosis of chronic psychotic disorder (e.g., schizophrenia or schizoaffective disorder) confirmed by psychiatric assessment and medical records.
- Presence of residual psychotic symptoms (positive symptoms such as hallucinations, delusions; and/or negative symptoms such as blunted affect, social withdrawal) despite ongoing psychotropic treatment.
- Medically stable and deemed suitable for participation by the treating psychiatrist or healthcare team.
- Patients who provide informed consent to participate in the rehabilitation program and research study.
Exclusion
- Acute medical or psychiatric conditions requiring immediate intervention.
- Developmental or intellectual disabilities that significantly impair participation in the rehabilitation program or assessments.
- Current substance dependence that would interfere with participation.
- Significant risk of harm to self or others, based on clinical assessment or history of violence/aggression.
- Contraindications to specific rehabilitation program components (e.g., physical exercise, group activities) as determined by medical evaluation.
- Inability to comprehend study requirements or provide informed consent due to language barriers, cognitive impairment, or other factors.
Key Trial Info
Start Date :
July 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT07183982
Start Date
July 10 2025
End Date
August 1 2025
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al Massara Hospital
Muscat, Muḩāfaz̧at Masqaţ, Oman